Patent · US Active

Pharmaceutical aerosol product for administration by oral or nasal inhalation

US11992556B2 · kind B2 · utility

0Cited by

10References

12Claims

0Family size

Assignee

Covis Pharma GmbH · CH

Inventors

Helgert Müller · Radolfzell, DE
Renate Engelstätter · Allensbach, DE
Ulrich Bildmann · Hilzingen, DE
Andrea Bauer · North Reading, US
Paul McGlynn · Northborough, US

Key dates

Filing date	May 13, 2021
Grant date	May 28, 2024
Priority date	—
Expiry date	May 13, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M15/009
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to a pharmaceutical aerosol product suitable for administration by oral or nasal inhalation and its use in the treatment of respiratory diseases, in particular in the treatment of children. The aerosol composition comprises ciclesonide, ethanol and either 1, 1, 1, 2-tetrafluoroethane, or 1, 1, 1, 2, 3, 3, 3-heptafluoropropane.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.